vs

Side-by-side financial comparison of CUMBERLAND PHARMACEUTICALS INC (CPIX) and Snail, Inc. (SNAL). Click either name above to swap in a different company.

Snail, Inc. is the larger business by last-quarter revenue ($25.1M vs $13.7M, roughly 1.8× CUMBERLAND PHARMACEUTICALS INC). Snail, Inc. runs the higher net margin — -3.4% vs -10.3%, a 6.9% gap on every dollar of revenue. On growth, CUMBERLAND PHARMACEUTICALS INC posted the faster year-over-year revenue change (31.1% vs -4.2%). Over the past eight quarters, Snail, Inc.'s revenue compounded faster (33.4% CAGR vs 26.9%).

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company that develops, manufactures and commercializes branded prescription medicines. Its core product portfolio covers acute care, gastroenterology, pain management and rare disease treatment, with its primary operating market being the United States, serving healthcare providers and patients in relevant care segments.

Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....

CPIX vs SNAL — Head-to-Head

Bigger by revenue
SNAL
SNAL
1.8× larger
SNAL
$25.1M
$13.7M
CPIX
Growing faster (revenue YoY)
CPIX
CPIX
+35.3% gap
CPIX
31.1%
-4.2%
SNAL
Higher net margin
SNAL
SNAL
6.9% more per $
SNAL
-3.4%
-10.3%
CPIX
Faster 2-yr revenue CAGR
SNAL
SNAL
Annualised
SNAL
33.4%
26.9%
CPIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPIX
CPIX
SNAL
SNAL
Revenue
$13.7M
$25.1M
Net Profit
$-1.4M
$-862.2K
Gross Margin
83.6%
38.3%
Operating Margin
-10.0%
-6.0%
Net Margin
-10.3%
-3.4%
Revenue YoY
31.1%
-4.2%
Net Profit YoY
25.8%
-177.0%
EPS (diluted)
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPIX
CPIX
SNAL
SNAL
Q4 25
$13.7M
$25.1M
Q3 25
$8.3M
$13.8M
Q2 25
$10.8M
$22.2M
Q1 25
$11.7M
$20.1M
Q4 24
$10.4M
$26.2M
Q3 24
$9.1M
$22.5M
Q2 24
$9.8M
$21.6M
Q1 24
$8.5M
$14.1M
Net Profit
CPIX
CPIX
SNAL
SNAL
Q4 25
$-1.4M
$-862.2K
Q3 25
$-1.9M
$-7.9M
Q2 25
$-740.7K
$-16.6M
Q1 25
$1.3M
$-1.9M
Q4 24
$-1.9M
$1.1M
Q3 24
$-1.5M
$235.1K
Q2 24
$-1.1M
$2.3M
Q1 24
$-1.9M
$-1.8M
Gross Margin
CPIX
CPIX
SNAL
SNAL
Q4 25
83.6%
38.3%
Q3 25
88.1%
0.1%
Q2 25
81.4%
31.3%
Q1 25
87.8%
29.1%
Q4 24
81.1%
43.3%
Q3 24
85.4%
38.6%
Q2 24
82.6%
37.5%
Q1 24
81.5%
14.7%
Operating Margin
CPIX
CPIX
SNAL
SNAL
Q4 25
-10.0%
-6.0%
Q3 25
-23.7%
-71.3%
Q2 25
-6.9%
-8.2%
Q1 25
11.0%
-20.4%
Q4 24
-17.7%
11.5%
Q3 24
-18.6%
1.8%
Q2 24
-10.4%
12.4%
Q1 24
-22.0%
-15.6%
Net Margin
CPIX
CPIX
SNAL
SNAL
Q4 25
-10.3%
-3.4%
Q3 25
-23.4%
-56.9%
Q2 25
-6.8%
-74.7%
Q1 25
10.7%
-9.7%
Q4 24
-18.2%
4.3%
Q3 24
-17.0%
1.0%
Q2 24
-11.0%
10.4%
Q1 24
-22.9%
-12.6%
EPS (diluted)
CPIX
CPIX
SNAL
SNAL
Q4 25
$-0.09
Q3 25
$-0.13
Q2 25
$-0.05
$-0.44
Q1 25
$0.08
$-0.06
Q4 24
$-0.13
$0.03
Q3 24
$-0.11
$0.01
Q2 24
$-0.08
$0.06
Q1 24
$-0.14
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPIX
CPIX
SNAL
SNAL
Cash + ST InvestmentsLiquidity on hand
$11.4M
$8.6M
Total DebtLower is stronger
$14.6M
Stockholders' EquityBook value
$24.9M
$-16.4M
Total Assets
$76.8M
$59.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPIX
CPIX
SNAL
SNAL
Q4 25
$11.4M
$8.6M
Q3 25
$15.2M
$12.3M
Q2 25
$16.1M
$7.9M
Q1 25
$15.1M
$9.4M
Q4 24
$18.0M
$7.3M
Q3 24
$17.5M
$10.6M
Q2 24
$17.3M
$15.5M
Q1 24
$18.5M
$16.1M
Total Debt
CPIX
CPIX
SNAL
SNAL
Q4 25
$14.6M
Q3 25
$10.5M
Q2 25
$11.8M
Q1 25
$9.0M
Q4 24
$5.7M
Q3 24
$5.7M
Q2 24
$5.8M
Q1 24
$6.5M
Stockholders' Equity
CPIX
CPIX
SNAL
SNAL
Q4 25
$24.9M
$-16.4M
Q3 25
$26.1M
$-15.6M
Q2 25
$28.0M
$-8.0M
Q1 25
$28.7M
$9.1M
Q4 24
$22.9M
$9.7M
Q3 24
$24.8M
$8.2M
Q2 24
$26.3M
$7.9M
Q1 24
$27.5M
$5.6M
Total Assets
CPIX
CPIX
SNAL
SNAL
Q4 25
$76.8M
$59.3M
Q3 25
$65.9M
$51.1M
Q2 25
$67.9M
$58.0M
Q1 25
$69.9M
$64.5M
Q4 24
$75.6M
$62.2M
Q3 24
$76.7M
$66.8M
Q2 24
$78.5M
$75.4M
Q1 24
$81.5M
$78.3M
Debt / Equity
CPIX
CPIX
SNAL
SNAL
Q4 25
Q3 25
Q2 25
Q1 25
0.99×
Q4 24
0.59×
Q3 24
0.70×
Q2 24
0.73×
Q1 24
1.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPIX
CPIX
SNAL
SNAL
Operating Cash FlowLast quarter
$3.0K
$-5.3M
Free Cash FlowOCF − Capex
$3.0K
FCF MarginFCF / Revenue
0.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPIX
CPIX
SNAL
SNAL
Q4 25
$3.0K
$-5.3M
Q3 25
$187.2K
$6.6M
Q2 25
$843.8K
$-3.2M
Q1 25
$3.9M
$764.5K
Q4 24
$1.9M
$-3.6M
Q3 24
$475.5K
$-5.0M
Q2 24
$-855.7K
$206.6K
Q1 24
$-2.1M
$6.8M
Free Cash Flow
CPIX
CPIX
SNAL
SNAL
Q4 25
$3.0K
Q3 25
$163.4K
Q2 25
$817.3K
Q1 25
$3.9M
Q4 24
$1.9M
Q3 24
$460.1K
Q2 24
$-862.8K
Q1 24
$-2.2M
FCF Margin
CPIX
CPIX
SNAL
SNAL
Q4 25
0.0%
Q3 25
2.0%
Q2 25
7.5%
Q1 25
32.9%
Q4 24
18.2%
Q3 24
5.1%
Q2 24
-8.8%
Q1 24
-25.6%
Capex Intensity
CPIX
CPIX
SNAL
SNAL
Q4 25
0.0%
Q3 25
0.3%
Q2 25
0.2%
Q1 25
0.4%
Q4 24
0.0%
Q3 24
0.2%
Q2 24
0.1%
Q1 24
0.5%
Cash Conversion
CPIX
CPIX
SNAL
SNAL
Q4 25
Q3 25
Q2 25
Q1 25
3.10×
Q4 24
-3.21×
Q3 24
-21.05×
Q2 24
0.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPIX
CPIX

Segment breakdown not available.

SNAL
SNAL

Pc$14.7M59%
Platform Three$5.2M21%
Platform Two$3.3M13%
Sales Channel Directly To Consumer Mobile Sale$1.6M6%

Related Comparisons